Back to Search
Start Over
Additional file 2: Figure S2. of Axitinib and sorafenib are potent in tyrosine kinase inhibitor resistant chronic myeloid leukemia cells
- Publication Year :
- 2016
- Publisher :
- Figshare, 2016.
-
Abstract
- (A/B) Western Blot quantification of Fig. 1d and 1G, n = 3, using FusionCapt 7.06 (Vilber Lourmat, Germany). (PDF 184 kb)
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi...........a74538dd058ca13d3e3a7f6c07c7eb5c
- Full Text :
- https://doi.org/10.6084/m9.figshare.c.3615767_d2.v1